Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study.
D000328:Adult; D000368:Aged; D001806:Blood Urea Nitrogen; D002712:Chlorides / Q000097:blood; D003404:Creatinine / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D005343:Fibrinolytic Agents; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010756:Phosphoric Acids / Q000097:blood; D010976:Platelet Count; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D006435:Renal Dialysis; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy; D013988:Ticlopidine
D002712:Chlorides; D005343:Fibrinolytic Agents; D010756:Phosphoric Acids; D011725:Pyridines; D013876:Thiophenes; D003404:Creatinine; D013988:Ticlopidine